scholarly journals Clinical Practice Guidelines for the Management of Temporomandibular Joint Disorders – A Review

2021 ◽  
Vol 10 (33) ◽  
pp. 2809-2815
Author(s):  
Indra Gopi ◽  
Arvind Muthukrishnan ◽  
Maragathavalli G.
Keyword(s):  
Clinical Practice ◽  
Temporomandibular Joint ◽  
Treatment Planning ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Treatment Guidelines ◽  
Third Molar ◽  
Mouth Opening ◽  
Temporomandibular Joint Disorders ◽  
Key Words Pain

BACKGROUND Temporomandibular joint disorders (TMD) are a group of disorders associated with temporomandibular joints, their associated muscles, and other related structures. TMD present with pain in the joints and related structures which can radiate to the neighbouring areas mimicking ear pains, headaches, neuropathic pain and odontogenic pain. Even though TMDs are more seen in both genders, the ratio of women reporting with TMD is higher (2:1) than men. Pain, the commonest symptom encountered, is usually chronic in duration and mild to severe in intensity. Various other signs and symptoms described are clicking or popping noise, deviation of the mandible, restricted mouth opening and jaw movements. Multiple factors have been reported as an aetiology, however, there is no definite established aetiology to cause TMD. Approaches to the management of TMDs require thorough history taking, clinical and radiological assessment and proper treatment planning. The signs, symptoms, and prevalence of the diseases are also necessary considerations in the treatment planning of TMDs. Traditional approaches in the management of TMDs involve systemic medications, physical therapies, and surgical interventions. The first line of systemic medications to be advised to relieve pain are analgesics. Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, muscle relaxants, barbiturates like benzodiazepine have been frequently administered. In recent times, extraction of impacted or buccoverted third molar teeth has also proven to be effective in reducing the pain associated with TMDs. The purpose of this study is to provide new clinical practice guidelines to establish a multidisciplinary approach in the management of patients with TMDs and to improve the patient’s quality of life (QoL). KEY WORDS Pain, Temporomandibular Joint Disorder, TMD, Treatment Guidelines

On what basis should we select treatment in clinical psychiatry: a question too obvious to ask?

2019 ◽  
Vol 28 (2) ◽  
pp. 202-205
Author(s):  
Sam Restifo ◽  
Lemuel Y H Tan
Keyword(s):  
Mental Illness ◽  
Clinical Practice ◽  
Treatment Planning ◽  
Clinical Psychiatry ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Research Evidence ◽  
Conceptual Models ◽  
Evidence Base ◽  
Medical Disciplines

Objective: Given the differences between our profession and the broader set of medical disciplines, a review of the factors to be considered in treatment planning was conducted. Conclusion: Treatment planning in psychiatry is inherently more complicated than in other medical disciplines for various reasons including: a broader range of conceptual models of mental illness and treatment; greater complexities around nosology and diagnosis; the greater limitations of the research evidence base and clinical practice guidelines; and the more substantial impacts of patients’ subjectivity and contextual aspects. Diagnosis is generally neither a sufficient nor necessarily the most useful criterion for treatment planning in psychiatry, with a number of other considerations to help guide treatment being outlined.

scholarly journals Optimizing the Clinical Utility of Biomarkers in Oncology: The NCCN Biomarkers Compendium

2014 ◽  
Vol 139 (5) ◽  
pp. 608-611 ◽  
Author(s):  
Marian L. Birkeland ◽  
Joan S. McClure
Keyword(s):  
Clinical Practice ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Treatment Guidelines ◽  
Rapid Development ◽  
Biological Information ◽  
Nccn Guidelines ◽  
Biomarker Testing ◽  
Oncology Care ◽  
Cancer Network

Context The rapid development of commercial biomarker tests for oncology indications has led to confusion about which tests are clinically indicated for oncology care. By consolidating biomarker testing information recommended within National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines), the NCCN Biomarkers Compendium aims to ensure that patients have access to appropriate biomarker testing based on the evaluations and recommendations of the expert NCCN panel members. Objectives To present the recently launched NCCN Biomarkers Compendium. Data Sources Biomarker testing information recommended within NCCN Clinical Treatment Guidelines as well as published resources for genetic and biological information. Conclusions The NCCN Biomarkers Compendium is a continuously updated resource for clinicians who need access to relevant and succinct information about biomarker testing in oncology and is linked directly to the recommendations provided within the NCCN Clinical Practice Guidelines.

scholarly journals Treatment guidelines in psoriatic arthritis

Rheumatology ◽  
2020 ◽  
Vol 59 (Supplement_1) ◽  
pp. i37-i46 ◽  
Author(s):  
Alexis Ogdie ◽  
Laura C Coates ◽  
Dafna D Gladman
Keyword(s):  
Clinical Practice ◽  
Psoriatic Arthritis ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Skin Disease ◽  
Treatment Guidelines ◽  
International Organization ◽  
The Past ◽  
Similarities And Differences ◽  
National Psoriasis Foundation

Abstract Psoriatic arthritis (PsA) is a complex inflammatory musculoskeletal and skin disease. The treatment of PsA has changed substantially over the past 10 years. Clinical practice guidelines are developed to help busy clinicians rapidly integrate evolving knowledge of therapeutic management into practice. In this review, we compare PsA treatment recommendations or guidelines developed by one national organization [ACR and National Psoriasis Foundation (NPF) in 2018], one regional organization (EULAR in 2015), and one international organization (the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis in 2015). We examine the development of guidelines in PsA more broadly and examine similarities and differences in the three sets of recommendations.

High Flow Oxygen Therapy and the Pressure to Feed Infants With Acute Respiratory Illness

2020 ◽  
Vol 5 (4) ◽  
pp. 1006-1010
Author(s):  
Jennifer Raminick ◽  
Hema Desai
Keyword(s):  
Clinical Practice ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Oxygen Therapy ◽  
Respiratory Illness ◽  
High Flow ◽  
Oral Feeding ◽  
Respiratory Support ◽  
Acute Respiratory Illness ◽  
High Flow Oxygen

Purpose Infants hospitalized for an acute respiratory illness often require the use of noninvasive respiratory support during the initial stage to improve their breathing. High flow oxygen therapy (HFOT) is becoming a more popular means of noninvasive respiratory support, often used to treat respiratory syncytial virus/bronchiolitis. These infants present with tachypnea and coughing, resulting in difficulties in coordinating sucking and swallowing. However, they are often allowed to feed orally despite having high respiratory rate, increased work of breathing and on HFOT, placing them at risk for aspiration. Feeding therapists who work with these infants have raised concerns that HFOT creates an additional risk factor for swallowing dysfunction, especially with infants who have compromised airways or other comorbidities. There is emerging literature concluding changes in pharyngeal pressures with HFOT, as well as aspiration in preterm neonates who are on nasal continuous positive airway pressure. However, there is no existing research exploring the effect of HFOT on swallowing in infants with acute respiratory illness. This discussion will present findings from literature on HFOT, oral feeding in the acutely ill infant population, and present clinical practice guidelines for safe feeding during critical care admission for acute respiratory illness. Conclusion Guidelines for safety of oral feeds for infants with acute respiratory illness on HFOT do not exist. However, providers and parents continue to want to provide oral feeds despite clinical signs of respiratory distress and coughing. To address this challenge, we initiated a process change to use clinical bedside evaluation and a “cross-systems approach” to provide recommendations for safer oral feeds while on HFOT as the infant is recovering from illness. Use of standardized feeding evaluation and protocol have improved consistency of practice within our department. However, further research is still necessary to develop clinical practice guidelines for safe oral feeding for infants on HFOT.

Sign in / Sign up

Export Citation Format

Share Document